TrinamiX, a Germany-based BASF subsidiary, has filed a patent lawsuit against Apple in the U.S. District Court for the Western District of Texas. The company alleges that Face ID in newer iPhones and iPads infringes seven patents covering skin and material detection, as first reported by MacRumors.
The complaint names multiple iPhone 15, iPhone 16, and iPhone 17 models, along with selected iPad Pro models. TrinamiX seeks damages, legal fees, a formal finding of infringement, and restrictions on Apple making, selling, or importing the accused devices. It has also requested a jury trial.
The patents center on detecting real skin
TrinamiX describes its technology as a way to determine whether a scanned object contains human skin and to identify the material involved. That capability can help a facial-authentication system identify presentation attacks, including photographs, masks, and silicone replicas, rather than treating them as a legitimate face scan.
Apple introduced Face ID with the iPhone X in 2017. TrinamiX’s complaint says the original iPhone X implementation did not use the technology at issue, while later versions allegedly do. The claim therefore focuses on a biometric feature used across newer premium iPhones and certain iPad Pro models rather than on Face ID’s first release.
Requested restrictions could affect current Apple hardware
The requested sales and import restrictions raise the stakes beyond a standard damages dispute. If granted, they would directly concern devices in Apple’s current iPhone and iPad lineup, though such remedies require a court ruling and are not automatic when a lawsuit is filed.
Apple has not been reported as responding to TrinamiX’s allegations, and the court has not determined whether any patent was infringed. The supplied summaries do not state the dollar amount TrinamiX is seeking, and it remains unclear whether the court will grant the requested restrictions on sales or imports.
This article was produced with AI assistance from multi-source reporting and is published under our editorial standards.
